Defining the apoptotic pathways underlying HDAC inhibitor-mediated tumor therapy in vivo

Lindemann, R., Newbold, A., Whitecross, K., Cluse, L., Frew, A., Ellis, L., Williams, S., Wiegmans, A., Dear, A., Scott, C., Pelligrini, M., Wei, A., Richon, V., Marks, P., Lowe, S. W., Smyth, M., Johnstone, R. (February 2008) Defining the apoptotic pathways underlying HDAC inhibitor-mediated tumor therapy in vivo. Onkologie, 31 (Suppl.). pp. 69-70. ISSN 0378-584X

URL: https://www.karger.com/Article/Abstract/115424
DOI: 10.1159/000115424
Item Type: Paper
Additional Information: Meeting Abstract
Subjects: diseases & disorders > cancer
diseases & disorders
therapies
organs, tissues, organelles, cell types and functions > cell types and functions > cell functions > apoptosis
organs, tissues, organelles, cell types and functions > cell types and functions > cell functions
organs, tissues, organelles, cell types and functions > cell types and functions
Publication Type > Meeting Abstract
organs, tissues, organelles, cell types and functions
CSHL Authors:
Communities: CSHL labs > Lowe lab
Depositing User: Matt Covey
Date: February 2008
Date Deposited: 28 Feb 2013 15:31
Last Modified: 19 Mar 2018 16:14
URI: http://repository.cshl.edu/id/eprint/27510

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving